[HTML][HTML] Pim-2 modulates aerobic glycolysis and energy production during the development of colorectal tumors

X Zhang, H Yu, F Wang, Y Han… - International journal of …, 2015 - ncbi.nlm.nih.gov
X Zhang, H Yu, F Wang, Y Han, W Yang
International journal of medical sciences, 2015ncbi.nlm.nih.gov
Tumor cells have higher rates of glucose uptake and aerobic glycolysis to meet energy
demands for proliferation and metastasis. The characteristics of increased glucose uptake,
accompanied with aerobic glycolysis, has been exploited for the diagnosis of cancers.
Although much progress has been made, the mechanisms regulating tumor aerobic
glycolysis and energy production are still not fully understood. Here, we demonstrate that
Pim-2 is required for glycolysis and energy production in colorectal tumor cells. Our results …
Abstract
Tumor cells have higher rates of glucose uptake and aerobic glycolysis to meet energy demands for proliferation and metastasis. The characteristics of increased glucose uptake, accompanied with aerobic glycolysis, has been exploited for the diagnosis of cancers. Although much progress has been made, the mechanisms regulating tumor aerobic glycolysis and energy production are still not fully understood. Here, we demonstrate that Pim-2 is required for glycolysis and energy production in colorectal tumor cells. Our results show that Pim-2 is highly expressed in colorectal tumor cells, and may be induced by nutrient stimulation. Activation of Pim-2 in colorectal cells led to increase glucose utilization and aerobic glycolysis, as well as energy production. While knockdown of Pim-2 decreased energy production in colorectal tumor cells and increased their susceptibility to apoptosis. Moreover, the effects of Pim-2 kinase on aerobic glycolysis seem to be partly dependent on mTORC1 signaling, because inhibition of mTORC1 activity reversed the aerobic glycolysis mediated by Pim-2. Our findings suggest that Pim-2-mediated aerobic glycolysis is critical for monitoring Warburg effect in colorectal tumor cells, highlighting Pim-2 as a potential metabolic target for colorectal tumor therapy.
ncbi.nlm.nih.gov